Celldex Therapeutics reported $345.42M in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agenus AGEN:US USD -20385000 23.8M
Amgen AMGN:US USD 3.65B 1.23B
Applied Genetic Technologies AGTC:US USD 17.65M 11.83M
Aptinyx Inc APTX:US USD 48.79M 13.31M
Bristol Myers Squibb BMY:US USD 32.67B 71M
Celldex Therapeutics CLDX:US USD 345.42M 19.68M
Cytrx CYTR:US USD 3.28M 1.5M
Glaxosmithkline GSK:US GBP 9.15B 7.22B
Immunogen IMGN:US USD 178.01M 71.82M
Nektar Therapeutics NKTR:US USD 412.22M 46.51M
Newlink Genetics NLNK:US USD 67.71M 6.84M
Northwest Biotherapeutics NWBO:US USD -95104000 3.44M
Rigel Pharmaceuticals RIGL:US USD 19.83M 23.51M
Seattle Genetics SGEN:US USD 2.82B 111M